Threatened abortion. Threatened abortion
Conditions
Interventions
Intervention 1: Intervention group 1: Didrogesterone tablet made by Abourihan Company, 10 mg twice a day (10 mg every 12 hours ) since the initial of the study up until one week after bleeding. Interv
Sponsors
Qazvin University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: Gestational age 6 to 13 weeks Observation of fetal heart rate Vaginal bleeding Absence of uterine anomalies Absence fetal anomalies
Exclusion criteria
Exclusion criteria: Breast carcinoma Severe liver problems Genital carcinoma Thromboembolic disorders Epilepsy Diabetes Hypertension
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Preeclampsia. Timepoint: Up to 28 weeks monthly and until 36 weeks every two weeks and thereafter weekly until delivery. Method of measurement: Sphygmometer.;Gestational Diabetes. Timepoint: Up to 28 weeks monthly and until 36 weeks every two weeks and then weekly until delivery. Method of measurement: Glucose tolerance test.;Preterm labor. Timepoint: Up to 28 weeks monthly and until 36 weeks every two weeks and then weekly until delivery. Method of measurement: Tocometry of uterus and delivery before 37 weeks of pregnancy.;Low birth weight. Timepoint: Weight immediately after birth. Method of measurement: Pediatric scales.;Abortion under 20 weeks of pregnancy. Timepoint: Every week from the start of the intervention up to 20 weeks of pregnancy. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Hamide pakniat
Qazvin University of Medical Sciences
Outcome results
None listed